Reversibility is assessed through a combination of experimental studies and clinical observations. Animal studies often involve removing the toxicant and observing the recovery process. Biomarkers are used to evaluate functional recovery, while histopathological examinations are used to assess structural repair. In humans, clinical trials and post-market surveillance provide data on the reversibility of adverse effects.
